Prolifagen

Philadelphia, United States

Prolifagen develops microRNA-based therapies for cardiac regeneration, aiming to prevent heart failure.

$3.0M raised

Sep 2025

Undisclosed

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Prolifagen

How much funding has Prolifagen raised?

Prolifagen has raised $3.0M in total funding. The most recent round was Undisclosed. The last funding was announced in September 2025.

Where is Prolifagen headquartered?

Prolifagen is headquartered in Philadelphia, United States.

What does Prolifagen do?

Prolifagen develops microRNA-based therapies for cardiac regeneration, aiming to prevent heart failure.

What stage is Prolifagen at?

Prolifagen is at the Undisclosed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 23, 2025.

MLA

"Prolifagen — Funding & Investors." VCBacked, September 23, 2025, https://www.vcbacked.co/company/prolifagen. Accessed July 2, 2026.

APA

VCBacked. (2025). Prolifagen — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/prolifagen

Wikipedia (cite web)

{{cite web |title=Prolifagen — Funding & Investors |url=https://www.vcbacked.co/company/prolifagen |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 23, 2025.